Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/7/26 18:52 | 7/2/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | 2 | S.m | -10,349 | 21.02 | 0 | -492 | 1,406 | D | |||||||||||||||
7/6/26 19:19 | 7/1/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Lo Francis | WA | O | Chief Pe | 2 | S.dm | -2,853 | 21.04 | 0 | -136 | 253 | D | |||||||||||||||
7/6/26 19:15 | 7/1/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Bobulsky Susan | WA | O | Chief Co | 4 | S | -406 | 18.91 | 0 | -21 | 417 | D | |||||||||||||||
6/30/26 19:25 | 6/26/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Benzeno Sharon | WA | O | Chief Co | 1 | S.dm | -3,504 | 21.13 | 0 | -166 | 221 | D | |||||||||||||||
6/29/26 19:49 | 6/25/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Griffin Michelle Renee | WA | D | 1 | S.d | -1,051 | 20.18 | 0 | -52 | 16 | D | ||||||||||||||||
5/20/26 19:13 | 5/18/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Piskel Kyle | WA | O | CFO | 1 | S | -41 | 13.04 | 0 | -3 | 257 | D | |||||||||||||||
4/29/26 19:08 | 4/27/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Rubinstein Julie | WA | O | P,COO | 3 | S.dm | -2,078 | 14.30 | 0 | -145 | 395 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |